Dipeptidyl Peptidase-4 Inhibitors and Cardiovascular Outcomes: Meta-Analysis of Randomized Clinical Trials with 55,141 Participants-Reference-Cited by-同舟云学术

Dipeptidyl Peptidase-4 Inhibitors and Cardiovascular Outcomes: Meta-Analysis of Randomized Clinical Trials with 55,141 Participants

Published:2014-07-09 Issue:4 Volume:32 Page:147-158
ISSN:1755-5914
Container-title:Cardiovascular Therapeutics
language:en
Short-container-title:Cardiovasc Ther

Author:

Wu Shiying¹,Hopper Ingrid¹²,Skiba Marina¹²,Krum Henry¹²

Affiliation:

1. Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health and Preventive Medicine; Monash University; Melbourne Vic Australia

2. Department of Clinical Pharmacology; The Alfred Hospital; Melbourne Vic Australia

Funder

NHMRC

Publisher

Wiley

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine

Reference71 articles.

1. The global burden of diabetes and its complications: an emerging pandemic;Dieren;Eur J Cardiovasc Prev Rehabil,2010

2. Type 2 diabetes, cardiovascular risk, and the link to insulin resistance;Stolar;Clin Ther,2003

3. Cardiovascular disease and oral agent glucose-lowering therapies in the management of type 2 diabetes;Home;Diabetes Technol Ther,2012

4. Rosiglitazone revisited: an updated meta-analysis of risk for myocardial infarction and cardiovascular mortality;Nissen;Arch Intern Med,2010

5. Thiazolidinediones and risk of heart failure in patients with or at high risk of type 2 diabetes mellitus: a meta-analysis and meta-regression analysis of placebo-controlled randomized clinical trials;Hernandez;Am J Cardiovasc Drugs,2011

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of SGLT2 Inhibitors, DPP-4 Inhibitors, and Metformin in Pancreatic Cancer Prevention;Cancers;2024-03-28

2. Endogenous glucagon‐like peptide (GLP)‐1 as alternative for GLP‐1 receptor agonists: Could this work and how?;Diabetes/Metabolism Research and Reviews;2023-07-24

3. Pattern, frequency and factors associated with inappropriate high dosing in chronic kidney disease patients at a tertiary care hospital in Pakistan;BMC Nephrology;2023-05-01

4. Heart failure and diabetes: Clinical significance and epidemiology of this two‐way association;Diabetes, Obesity and Metabolism;2023-04-05

5. Commentary on cardiovascular safety of DPP4Is: Focus on Alogliptin;Indian Journal of Pharmacy and Pharmacology;2023-03-15